REFERENCES
1. Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2021;7:6.
2. Asafo-Agyei KO, Samant H. Hepatocellular carcinoma. Available from: http://www.ncbi.nlm.nih.gov/books/NBK559177/ [Last accessed on 8 Apr 2024].
3. Balogh J, Victor D 3rd, Asham EH, et al. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 2016;3:41-53.
4. Colagrande S, Regini F, Taliani GG, Nardi C, Inghilesi AL. Advanced hepatocellular carcinoma and sorafenib: diagnosis, indications, clinical and radiological follow-up. World J Hepatol 2015;7:1041-53.
5. Allaire M, Goumard C, Lim C, Le Cleach A, Wagner M, Scatton O. New frontiers in liver resection for hepatocellular carcinoma. JHEP Rep 2020;2:100134.
7. Madkhali AA, Fadel ZT, Aljiffry MM, Hassanain MM. Surgical treatment for hepatocellular carcinoma. Saudi J Gastroenterol 2015;21:11-7.
8. Olthoff KM. Surgical options for hepatocellular carcinoma: resection and transplantation. Liver Transpl Surg 1998;4:S98-104.
9. Chapman WC, Klintmalm G, Hemming A, et al. Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified? J Am Coll Surg 2015;220:628-37.
10. Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet 2022;400:1345-62.
11. Pravisani R, Baccarani U, Isola M, et al. Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection. Updates Surg 2018;70:57-66.
12. Kaneko J, Kokudo T, Inagaki Y, Hasegawa K. Innovative treatment for hepatocellular carcinoma (HCC). Transl Gastroenterol Hepatol 2018;3:78.
13. Shirata C, Kaneko J, Inagaki Y, et al. Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress. Sci Rep 2017;7:13958.
14. Yao S, Zhang L, Ma J, Jia W, Chen H. Precise right hemihepatectomy for the treatment of hepatocellular carcinoma guided by fusion ICG fluorescence imaging. J Cancer 2020;11:2465-75.
15. Sebagh M, Desterke C, Feray C, et al. Indocyanine green fluorescence patterns of hepatocellular carcinoma correlate with pathological and molecular features. HPB 2023;25:198-209.
16. Huang SW, Ou JJ, Wong HP. The use of indocyanine green imaging technique in patient with hepatocellular carcinoma. Transl Gastroenterol Hepatol 2018;3:95.
17. Liu F, Wang H, Ma W, et al. Short- and long-term outcomes of indocyanine green fluorescence navigation- versus conventional-laparoscopic hepatectomy for hepatocellular carcinoma: a propensity score-matched, retrospective, cohort study. Ann Surg Oncol 2023;30:1991-2002.
18. Urade T, Sawa H, Iwatani Y, et al. Laparoscopic anatomical liver resection using indocyanine green fluorescence imaging. Asian J Surg 2020;43:362-8.
19. Qian X, Hu W, Gao L, et al. Trans-arterial positive ICG staining-guided laparoscopic liver watershed resection for hepatocellular carcinoma. Front Oncol 2022;12:966626.
20. Nanashima A, Hiyoshi M, Imamura N, Yano K, Hamada T, Kai K. Recent advances in photodynamic imaging and therapy in hepatobiliary malignancies: clinical and experimental aspects. Curr Oncol 2021;28:4067-79.
21. Park JS, Park S, Park SJ, Kim SK. Synergistic effects of concurrent photodynamic therapy with indocyanine green and chemotherapy in hepatocellular carcinoma cell lines and mouse models. J Photochem Photobiol B 2023;239:112642.
22. Wang Q, Zhong YJ, Yuan JP, et al. Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study. J Transl Med 2013;11:192.
23. Zhang Z, Hu K, Miyake K, et al. A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations. Sci Rep 2020;10:20105.
24. Hong F, Park JS, Kim SW, Park SJ, Kim SK. Near-infrared phototherapy for patient-derived orthotopic xenograft model of hepatocellular carcinoma in combination with indocyanine green. J Photochem Photobiol B 2020;209:111938.
25. Hu B, Li H, Guo W, et al. Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification. Int J Cancer 2020;146:1606-17.
26. Zhang Y, Zhang GL, Sun X, et al. Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation. Oncol Lett 2018;15:6233-40.
27. Kumar A, Moralès O, Mordon S, Delhem N, Boleslawski E. Could photodynamic therapy be a promising therapeutic modality in hepatocellular carcinoma patients? A critical review of experimental and clinical studies. Cancers 2021;13:5176.
28. Peng Z, Lv X, Huang S. Photoimmunotherapy: a new paradigm in solid tumor immunotherapy. Cancer Control 2022;29:107327482210888.
29. Sevieri M, Silva F, Bonizzi A, et al. Indocyanine green nanoparticles: are they compelling for cancer treatment? Front Chem 2020;8:535.
30. Gunaydin G, Gedik ME, Ayan S. Photodynamic therapy-current limitations and novel approaches. Front Chem 2021;9:691697.
31. Sun B, Bte Rahmat JN, Zhang Y. Advanced techniques for performing photodynamic therapy in deep-seated tissues. Biomaterials 2022;291:121875.
32. Dinakaran D, Wilson BC. The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy. Front Bioeng Biotechnol 2023;11:1250804.
33. Bae KH, Chung HJ, Park TG. Nanomaterials for cancer therapy and imaging. Mol Cells 2011;31:295-302.
34. Kamkaew A, Cheng L, Goel S, et al. Cerenkov radiation induced photodynamic therapy using chlorin e6-loaded hollow mesoporous silica nanoparticles. ACS Appl Mater Interfaces 2016;8:26630-7.
35. Du W, Wang Y, Luo Q, Liu BF. Optical molecular imaging for systems biology: from molecule to organism. Anal Bioanal Chem 2006;386:444-57.
36. Kim J, Kim J, Yoon H, Chae YJ, Rhew K, Chang JE. The in vitro and in vivo anticancer effect of photomed for photodynamic therapy: comparison with photofrin and radachlorin. Curr Issues Mol Biol 2023;45:2474-90.
37. Cuenca RE, Allison RR, Sibata C, Downie GH. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol 2004;11:322-7.
38. Zhao H, Xu J, Feng C, et al. Tailoring aggregation extent of photosensitizers to boost phototherapy potency for eliciting systemic antitumor immunity. Adv Mater 2022;34:e2106390.
39. Tseng HC, Kuo CY, Liao WT, Chou TS, Hsiao JK. Indocyanine green as a near-infrared theranostic agent for ferroptosis and apoptosis-based, photothermal, and photodynamic cancer therapy. Front Mol Biosci 2022;9:1045885.
40. Sekar R, Basavegowda N, Thathapudi JJ, et al. Recent progress of gold-based nanostructures towards future emblem of photo-triggered cancer theranostics: a special focus on combinatorial phototherapies. Pharmaceutics 2023;15:433.
41. Mahmut Z, Zhang C, Ruan F, et al. Medical applications and advancement of near infrared photosensitive indocyanine green molecules. Molecules 2023;28:6085.
42. Li B, Sun L, Li T, et al. Ultra-small gold nanoparticles self-assembled by gadolinium ions for enhanced photothermal/photodynamic liver cancer therapy. J Mater Chem B 2021;9:1138-50.
43. Chuang CC, Chen YN, Wang YY, et al. Stem cell-based delivery of gold/chlorin e6 nanocomplexes for combined photothermal and photodynamic therapy. ACS Appl Mater Interfaces 2020;12:30021-30.
44. Qi S, Zhang Y, Liu G, et al. Plasmonic-doped melanin-mimic for CXCR4-targeted NIR-II photoacoustic computed tomography-guided photothermal ablation of orthotopic hepatocellular carcinoma. Acta Biomater 2021;129:245-57.
45. Ni J, Wang Y, Zhang H, Sun JZ, Tang BZ. Aggregation-induced generation of reactive oxygen species: mechanism and photosensitizer construction. Molecules 2021;26:268.
46. Meng Z, Xue H, Wang T, et al. Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical. J Nanobiotechnology 2022;20:344.
47. Teng M, Chen Y, Xie Y, et al. Bright near-infrared aggregation-induced emission dots for long-term bioimaging in vitro/vivo. Dyes Pigments 2021;195:109679.
48. Xia Q, Chen Z, Zhou Y, Liu R. Near-infrared organic fluorescent nanoparticles for long-term monitoring and photodynamic therapy of cancer. Nanotheranostics 2019;3:156-65.
49. Trevisani F, Brandi G, Garuti F, et al. Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. J Cancer Res Clin Oncol 2018;144:403-14.
50. Granito A, Marinelli S, Terzi E, et al. Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure. Dig Liver Dis 2015;47:518-22.
51. Ma Z, Ji T, Ji G, Niu Q, Han W. Facile construction of dual-drug loaded nanoparticles for improvement synergistic chemotherapy in prostate cancer. Int J Polym Mater Polym Biomater 2023;72:856-66.
52. Yorozu K, Kaibori M, Kimura S, et al. Experience with photodynamic therapy using indocyanine green liposomes for refractory cancer. J Pers Med 2022;12:1039.
53. Gu Z, Da Silva CG, Van der Maaden K, Ossendorp F, Cruz LJ. Liposome-based drug delivery systems in cancer immunotherapy. Pharmaceutics 2020;12:1054.
54. Inagaki FF, Takemura N, Ito K, Mihara F, Kurokawa T, Kokudo N. Intraoperative indocyanine green fluorescence navigation facilitates complete removal of lymph node metastases from hepatocellular carcinoma. Glob Health Med 2021;3:406-8.
55. Chow AK, Yau SW, Ng L. Novel molecular targets in hepatocellular carcinoma. World J Clin Oncol 2020;11:589-605.
56. Hoshida Y, Fuchs BC, Tanabe KK. Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets 2012;12:1129-59.
57. Chen Z, Xie H, Hu M, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res 2020;10:2993-3036.
58. Chakraborty E, Sarkar D. Emerging therapies for hepatocellular carcinoma (HCC). Cancers 2022;14:2798.
59. Tsuda T, Kaibori M, Hishikawa H, et al. Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma. PLoS One 2017;12:e0183527.
60. Qi S, Liu G, Chen J, et al. Targeted multifunctional nanoplatform for imaging-guided precision diagnosis and photothermal/photodynamic therapy of orthotopic hepatocellular carcinoma. Int J Nanomed 2022;17:3777-92.
61. Shemesh CS, Hardy CW, Yu DS, Fernandez B, Zhang H. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells. Photodiagnosis Photodyn Ther 2014;11:193-203.
